Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Argos Therapeutics (ARGSQ)

Argos Therapeutics (ARGSQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Argos Therapeutics 4233 TECHNOLOGY DR DURHAM NC 27704 USA

www.argostherapeutics.com P: 919-287-6300

Description:

Argos Therapeutics is a biopharmaceutical company which focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis (TM) technology platform. Argos Therapeutics is based in Durham, United States.

Key Statistics

Overview:

Market Capitalization, $K 567
Shares Outstanding, K 10,587
Annual Sales, $ 1,900 K
Annual Net Income, $ -40,580 K
60-Month Beta 2.47
% of Insider Shareholders 28.21%
% of Institutional Shareholders 0.00%
Float, K 7,600
% Float 71.79%

Growth:

1-Year Return -55.33%
3-Year Return -99.95%
5-Year Return -99.97%
5-Year Revenue Growth -73.01%
5-Year Earnings Growth 98.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 09/30/19
Earnings Per Share ttm -0.47
EPS Growth vs. Prev Qtr 22.95%
EPS Growth vs. Prev Year 76.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/19/18

ARGSQ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -2,135.79%
Debt/Equity N/A
Price/Sales 0.45
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -29.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar